Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000652058 | SCV000773926 | uncertain significance | Vasculitis due to ADA2 deficiency | 2022-09-01 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid, which is acidic and polar, with glutamine, which is neutral and polar, at codon 489 of the ADA2 protein (p.Glu489Gln). This variant is present in population databases (rs45497794, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with ADA2-related conditions. ClinVar contains an entry for this variant (Variation ID: 541736). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Genome Diagnostics Laboratory, |
RCV002263907 | SCV002543375 | uncertain significance | Autoinflammatory syndrome | 2017-07-18 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002493046 | SCV002776028 | uncertain significance | Sneddon syndrome; Vasculitis due to ADA2 deficiency | 2021-11-24 | criteria provided, single submitter | clinical testing |